This inventor holds 1 USPTO granted patent. Top assignee: The Hong Kong University of Science and Technology. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: David Charles New: Innovator in Melatonin Receptor Research
Introduction
David Charles New is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of pharmacology, particularly in the treatment of conditions associated with melatonin receptors. His innovative approach has led to the development of a unique pharmaceutical composition aimed at improving health outcomes.
Latest Patents
David Charles New holds 1 patent related to a method of treating, preventing, or ameliorating a pathological condition associated with a melatonin receptor in mammals. This patent involves a pharmaceutical composition containing a compound that interacts with the melatonin receptor, showcasing his expertise in this specialized area of research.
Career Highlights
David is affiliated with The Hong Kong University of Science and Technology, where he continues to advance his research and contribute to the academic community. His work is characterized by a commitment to innovation and the application of scientific principles to real-world health challenges.
Collaborations
Throughout his career, David has collaborated with esteemed colleagues, including Xixin He and Haihong Pang. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.
Conclusion
David Charles New exemplifies the spirit of innovation in the field of pharmacology, particularly through his work on melatonin receptors. His contributions are paving the way for new therapeutic approaches that could benefit many individuals.